Gracell Biotechnologies to Report Fourth Quarter 2022 Financ

Gracell Biotechnologies to Report Fourth Quarter 2022 Financials on Monday, March 13, 2023

/PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to...

Related Keywords

China , Shanghai , Suzhou , Jiangsu , Marvin Tang , Kyle Evans , Gracell Biotechnologies Inc , Nasdaq , Gracell Biotechnologies ,

© 2025 Vimarsana